captopril has been researched along with ave 0991 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, E; Chen, J; Janda, A; Kwartler, CS; Milewicz, DM; Peters, AM; Wang, S; Zhou, P; Zhou, Z | 1 |
| Djerada, Z | 1 |
2 other study(ies) available for captopril and ave 0991
| Article | Year |
|---|---|
Reversal of Aortic Enlargement Induced by Increased Biomechanical Forces Requires AT1R Inhibition in Conjunction With AT2R Activation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Aortic Aneurysm; Aortitis; Biomechanical Phenomena; Captopril; Constriction; Hypertension; Imidazoles; Losartan; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Random Allocation; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Vascular Remodeling | 2019 |
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats.
Topics: Animals; Captopril; Imidazoles; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2021 |